Regent Pharmaceuticals is Other Pharmaceuticals and Biotechnology in United Kingdom that focus on larger pharmaceutical formulators business. Founded in 2013. They cover business area such as manufacturer, distributor, healthcare product, pharmaceutical company, retail pharmacy, clinic, medicinal cannabis distribution, an active Pharmaceutical Ingredient.
Other Pharmaceuticals and Biotechnology
2013
( 11 years old in 2024 )
Larger Pharmaceutical Formulators
-
5 Darlington Close
Sandy SG19 1RW
England, United Kingdom
Private
manufacturerdistributorhealthcare productpharmaceutical companyretail pharmacyclinicmedicinal cannabis distributionan active Pharmaceutical Ingredient
* We use standard office opening hours in near Regent Pharmaceuticals's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Regent Pharmaceuticals is Other Pharmaceuticals and Biotechnology business from United Kingdom that founded in 2013 (11 years old in 2024), Regent Pharmaceuticals business is focusing on Larger Pharmaceutical Formulators.
Regent Pharmaceuticals headquarter office and corporate office address is located in 5 Darlington Close Sandy SG19 1RW England, United Kingdom.
Regent Pharmaceuticals was founded in United Kingdom.
In 2024, Regent Pharmaceuticals is currently focus on larger pharmaceutical formulators sector.
Above is snippet of Google Trends for "larger pharmaceutical formulators" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Regent Pharmaceuticals, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
